OM
CPXX

Opaleye Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Opaleye Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-405,000
Closed -$1.02M – 41
2014
Q3 		$1.02M Buy
405,000
+66,598
+20% +$182K 0.8% 28
2014
Q2 		$1.07M Buy
338,402
+13,402
+4% +$36.9K 0.93% 23
2014
Q1 		$1.03M Buy
325,000
+15,000
+5% +$50.8K 0.76% 26
2013
Q4 		$961K Buy
+310,000
New +$1.06M 0.75% 23

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Opaleye Management's CPXX Position: Q4 2014 in Review

Opaleye Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q4 2014, closing a stake of 405,000 shares — an estimated $1.02M sold.

Opaleye Management first reported a position in CPXX in Q4 2013 and held it in 4 quarters. The position peaked at $1.07M in Q2 2014. 14 funds tracked by Wall St. Rank hold CPXX as of Q4 2014.

  • Opaleye Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q4 2014 after selling out during the quarter.
  • Opaleye Management sold 405,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q4 2014, an estimated $1.02M.
  • Opaleye Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2013 and held it in 4 quarters.
  • Opaleye Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $1.07M in Q2 2014.
  • 14 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q4 2014.

Based on Opaleye Management's 13F filing for Q4 2014, filed 13 Feb 2015.